期刊文献+

组蛋白乙酰化修饰调控RAR-β2表达与宫颈病变的相关性 被引量:3

Correlation between cervical lesion development and histone acetylation modification that regulates RAR-β_2 expression
下载PDF
导出
摘要 目的:探讨组蛋白乙酰化修饰与RAR-β2表达及宫颈病变发生发展的关系。方法:收集正常宫颈、宫颈上皮内瘤变(cervical intraepithelial neoplasia,CIN)Ⅱ-Ⅲ和宫颈鳞状细胞癌(squamous cell carcinoma,SCC)组织,分别采用免疫组织化学和WesternBlot方法检测AcH3、RAR—B:和Involucrin的表达;分析组蛋白乙酰化水平与RAR-β2表达及宫颈病变程度的关系。结果:随着宫颈病变的进展,AcH3、RAR-β2和Involucrin的表达逐渐降低,甚至缺失,组间差异有统计学意义(P〈0.05);组蛋白乙酰化水平与RAR-β2表达呈正相关(r=0.797,P〈0.05),AcH3和RAR-β2的表达均与宫颈病变程度呈负相关[r=-0.5479(Ach3),r=-0.585(RAR-β2),P〈0.05]。结论:组蛋白乙酰化修饰与RAR-β2表达调控有关,并可能参与宫颈癌的发生。 Objective: To investigate the relationship between cervical lesion development and histone acetylation that regulates RAR-β2 expression. Methods: Immunohistochemistry and Western blot analysis were performed to detect AcH3, RAR-β2, and involu- crin expression in normal cervical tissues as well as in tissues with cervical intraepithelial neoplasia (CIN) Ⅱ-Ⅲ and squamous cell cer-vical carcinoma. The relationship among histone acetylation level, RAR-β2 expression, and cervical lesion severity were analyzed. Re-suits: AcH3, RAR-β2, and involucrin expression were reduced or absent with the progression of cervical lesions; significant differences were noted between the groups (P〈0.05). Histone acetylation level and RAR-132 expression were positively correlated (r=0.797, P〈 0.05). AcH3 and RAR-132 expression, which were both associated with the cervical lesions, were negatively correlated [r=-0.547(AcH3), r=-0.585(RAR-β2), P〈0.05]. Conclusion: Histone acetylation modification is associated with the regulation of RAR-β2 expression. This pro-cess is also likely to participate in the carcinogenesis of cervical carcinoma.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2014年第5期300-304,共5页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金项目(编号:81072127,30901606) 安徽省自然科学基金项目(编号:11040606M176) 安徽医科大学高校科研基金项目(编号:2012XKJ046)资助~~
关键词 组蛋白乙酰化修饰 RAR-β2 宫颈上皮内瘤变 宫颈鳞状细胞癌 分化 histone acetylation modification, RAR-]32, cervical intraepithelial neoplasia, squamous cell cervical carcinoma, differ-entiation
  • 相关文献

参考文献15

  • 1Ralhan R,Chakravarti N,Kaur J. Clinical significance of al-tered expression of retinoid receptors in oral precancerous and can-cerous lesions:Relationship with cellcycle regulators[J].Int J Can-cer,2006,(05):1077-1089.
  • 2黄泓,王立峰,田海梅,刘毅,李茉,曲平,王吾茹,张伟.维甲酸受体-β等肿瘤分子标志物在食管正常及异常组织中的表达及意义[J].中华肿瘤杂志,2005,27(3):152-155. 被引量:6
  • 3Zhang Z,Joh K,Yatsuki H. Retinoic acid receptor beta2 is epi-genetical y silenced either by DNA methylation or repressive his-tone modifications at the promoter in cervical cancer cells[J].Can-cer Lett,2007,(02):318-327.
  • 4Feng DQ,Wu J,Tian Y. Targeting of histone deacetylases to reactivate tumour suppressor genes and its therapeutic potential in a human cervical cancer xenograft model[J].PLoS ONE,2013,(11):e80657.
  • 5Cheng Y,Zhou Y,Jiang W. Significance of E-cadherin,β-catenin,and vimentin expression as postoperative prognosis indi-cators in cervical squamous cellcarcinoma[J].{H}Human Pathology,2012,(08):1213-1220.
  • 6Mahlknecht U,Hoelzer D. Histoneacetylation modifiers in the pathogenesis of malignant disease[J].{H}Molecular Medicine,2000,(08):623-644.
  • 7Berqada L,Sorol a A,Yeramian A. Combination of Vorino-stat and caspase-8 inhibition exhibits high anti-tumoral activity on endometrial cancer cells[J].Mol Oncol,2013,(04):763-775.
  • 8Mateen S,Raina K,Jain AK. Epigenetic modifications and p21-cyclin B1 nexus in anticancer effect of histone deacetylase in-hibitors in combination with silibinin on non-smal celllung cancer cells[J].Epigenetics,2012,(10):1161-1172.
  • 9Meng F,Sun G,Zhong M. Inhibition of DNA methyltransfer-ases,histone deacetylases and lysine-specific demethylase-1 sup-presses the tumorigenicity of the ovarian cancer ascites cellline SKOV3[J].{H}International Journal of Oncology,2013,(02):495-502.
  • 10贾妍,邹颖刚,陈军,黄冰玉,崔满华.组蛋白去乙酰化酶1在人上皮性卵巢癌组织中的表达[J].中国实验诊断学,2011,15(2):256-258. 被引量:4

二级参考文献67

  • 1高艳萍,李敏,张颖颖,王翰,贺小红,王泽华.子宫颈癌发生发展中维甲酸受体-β基因启动子甲基化状态的研究[J].肿瘤研究与临床,2008,20(4):250-253. 被引量:2
  • 2Takai N,Narahara H.Histone deacetylase inhibitor therapy in epithelial ovarian cancer[J].J Oncol,2010,458431.
  • 3Sant'Ana de Almeida EC,Nogueira AA,Candido dos Reis FJ,et al.Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women[J].Maturitas,2004,49 (3):229.
  • 4Taunton J,Hassig CA,Schreiber SL.A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p[J].Science,1996,272:408.
  • 5Khabele D,Son DS,Parl AK,et al.Drug-induced inactivation or gene silencing of class 1 histone deacetylases suppresses ovarian cancer cell growth:implications for therapy[J].Cancer Biol Ther,2007,6:795.
  • 6Lin CT,Lai HC,Lee HY,et al.Valproic acid resensitizes cisplatin-resistant ovarian cancer cells[J].Cancer Sci,2008,99(6):1218.
  • 7Yang YT,Balch C,Kulp SK,et al.A rationally designed histone deacetylase inhibitor with distinct antitumor activity against ovarian cancer[J].Neoplasia,2009,11(6):552.
  • 8Dreger P, Klss M, Petersen B, et al.Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not bone marrow grafts[J].Blood, 1995,86(10):3970-3978.
  • 9Jones PA, Laird PW.Cancer epigentics comes of age[J].Nat Genet,1999,21(2):163-167.
  • 10Jones PA,Takai D.The role of DNA methylation in mammalian epigenetics[J].Science, 2001,293(5532):1068-1070.

共引文献21

同被引文献54

  • 1Saavedra KP,Brebi PM,Roa JC.Epigenetic alterations in preneoplastic and neoplastic lesions of the cervix[J].Clin Epigenetics,2012,4(1):13.
  • 2Jeronimo C,Bastian PJ,Bjartell A,et al.Epigenetics in prostate cancer:biologic and clinical relevance[J].Eur Urol,2011,60(4):753-766.
  • 3Jiang J,Zhao LJ,Zhao C,et al.Hypomethylated Cp G around the transcription start site enables TERT expression and HPV16 E6 regulates TERT methylation in cervical cancer cells[J].Gynecol Oncol,2012,124(3):534-541.
  • 4Banzai C,Nishino K,Quan J,et al.Promoter methylation of DAPK1,FHIT,MGMT,and CDKN2A genes in cervical carcinoma[J].Int J Clin Oncol,2013,19(1):127-132.
  • 5Pan Z,Zheng W,Zhang J,et al..Down-regulation of the expression of CCAAT/enhancer binding protein alpha gene in cervicalsquamous cell carcinoma[J].BMC Cancer,2014,14(1):417.
  • 6Yang N,Nijhuis ER,Volders HH,et al.Gene promoter methylation patterns throughout the process of cervical carcinogenesis[J].Cell Oncol,2010,32(1-2):131-143.
  • 7Overmeer RM,Henken FE,Snijders P J,et al.Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC[J].J Pathol,2008,215(4):388-397.
  • 8Bierkens M,Hesselink AT,Meijer CJ,et al.CADM1 and MAL promoter methylation levels in hr HPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease[J].Int J Cancer,2013,133(6):1293-1299.
  • 9Jacquin E,Baraquin A,Ramanah R,et al,Methylation of Human Papillomavirus Type 16 Cp G Sites at E2-Binding Site 1(E2BS1),E2BS2,and the Sp1-Binding Site in Cervical Cancer Samples as Determined by High-Resolution Melting Analysis-PCR[J].J Clin Microbiol,2013,51(10):3207-3215.
  • 10Ding DC,Chiang MH,Lai HC,et al,Methylation of the long control region of HPV16 is related to the severity of cervical neoplasia[J].Eur J Obstet Gynecol Reprod Biol,2009,147(2):215-220.

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部